LIG-ES SPAC
Chemtros Co., Ltd. engages in the manufacture and sale of chemical intermediates, and applied materials and adhesives in South Korea. The company offers products in the area of electronic materials, including materials at the display field, such as OLED, LCD, etc.; and additives for secondary cells for smartphone, tablet PC, electric automobile, rechargeable battery, etc. It also offers polymer a… Read more
LIG-ES SPAC (220260) - Total Liabilities
Latest total liabilities as of September 2025: ₩54.42 Billion KRW
Based on the latest financial reports, LIG-ES SPAC (220260) has total liabilities worth ₩54.42 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
LIG-ES SPAC - Total Liabilities Trend (2016–2024)
This chart illustrates how LIG-ES SPAC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
LIG-ES SPAC Competitors by Total Liabilities
The table below lists competitors of LIG-ES SPAC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Adicet Bio Inc
NASDAQ:ACET
|
USA | $33.15 Million |
|
PEDEVCO Corp
NYSE MKT:PED
|
USA | $20.52 Million |
|
Solytech Enterprise Corp
TW:1471
|
Taiwan | NT$122.33 Million |
|
BriQ Properties Real Estate Investment Company
AT:BRIQ
|
Greece | €131.75 Million |
|
AAC Clyde Space AB
OTCQX:ACCMF
|
USA | $184.77 Million |
|
Mevaco S.A
AT:MEVA
|
Greece | €26.61 Million |
|
Media Capital
LS:MCP
|
Portugal | €98.83 Million |
|
China Fineblanking Technology Co Ltd
TWO:1586
|
Taiwan | NT$1.87 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down LIG-ES SPAC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.83 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.83 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LIG-ES SPAC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LIG-ES SPAC (2016–2024)
The table below shows the annual total liabilities of LIG-ES SPAC from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩59.04 Billion | +63.26% |
| 2023-12-31 | ₩36.16 Billion | -6.10% |
| 2022-12-31 | ₩38.51 Billion | -4.36% |
| 2021-12-31 | ₩40.26 Billion | +58.34% |
| 2020-12-31 | ₩25.43 Billion | +8.10% |
| 2019-12-31 | ₩23.52 Billion | -19.35% |
| 2018-12-31 | ₩29.17 Billion | +36.30% |
| 2017-12-31 | ₩21.40 Billion | +4549.07% |
| 2016-12-31 | ₩460.27 Million | -- |